Trial record 1 of 3 for:    GU10-147
Previous Study | Return to List | Next Study

First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Hoosier Cancer Research Network
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Hoosier Cancer Research Network Identifier:
First received: October 4, 2010
Last updated: April 14, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)